We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sheds More Light on Infectious Disease Drug Designations
FDA Sheds More Light on Infectious Disease Drug Designations
The FDA has finalized guidance on qualified infectious disease product (QIDP) designations, drug designations that are meant to encourage the development of certain antibacterial and antifungal products for serious or life-threatening infections.